Introducing Luforbec 100/6 pMDI, the first branded generic alternative to Fostair^®1

Luforbec is a inhaled combination therapy containing beclometasone (100mcg) and formoterol (6mcg) in a pressurised metered dose inhaler (pMDI).

Luforbec is indicated for the treatment of adult asthma and for the symptomatic treatment of COPD (FEV₁ <50% predicted normal)²

Release savings with the first branded generic alternative to Fostair^® 100/6 pMDI¹

Save 30% with Luforbec 100/6 pMDI vs Fostair 100/6 pMDI list price¹

Prescribe Luforbec by
brand to release savings

Fostair 100/6 pMDI and Luforbec 100/6 pMDI are both Category C medicines, therefore Luforbec must be prescribed by brand to release savings for the NHS¹

If you would like to know more about Luforbec and the savings opportunities available, please get in touch by email to:
UKRespiratory@lupin.com or call on: 01565 751378

Luforbec 100/6 pMDI has the same licensed indications as Fostair 100/6 pMDI^2,3

ASTHMA – Luforbec is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta₂-agonist) is appropriate:
– patients not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled rapid-acting beta₂-agonist or
– patients already adequately controlled on both inhaled corticosteroids and long-acting beta₂-agonists
Luforbec 100/6 can also be used for Maintenance and Reliever Therapy (MART) for adult asthma²

COPD – Symptomatic treatment of patients with severe COPD (FEV₁ < 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators

Fostair^® is a registered trademark of Chiesi Ltd
References: 1. NHS BSA. Drug Tariff. https://www.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance-contractors/drug-tariff. Accessed August 2021 2. Luforbec Summary of Product Characteristics. Lupin Healthcare UK Limited.  3. Fostair Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/6318/smpc#gref. Accessed: August 2021